Neuro-Oncology Clinicians’ Attitudes and Perspectives on Medical Assistance in Dying
Authors:
- Seth A. ClimansSCSeth A. Climans
- Warren P. MasonWMWarren P. Mason
- Caroline VariathCVCaroline Variath
- Kim EdelsteinKEKim Edelstein
- Jennifer A. H. BellJBJennifer A. H. Bell
- 29 July 2021
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 48 (6) , 1-7
Abstract
Background: Medical assistance in dying (MAiD), also known as physician-assisted death, is currently legal in several locations across the globe. Brain cancer or its treatments can lead to cognitive impairment, which can impact decision-making capacity for MAiD. Objective: We sought to explore neuro-oncology clinicians’ attitudes and perspectives on MAiD, including interpretation of decision-making capacity for patient MAiD eligibility. Methods: An online survey was distributed to members of national and international neuro-oncology societies. We asked questions about decision-making capacity and MAiD, in part using hypothetical patient scenarios. Multiple choice and free-text responses were captured. Results: There were 125 survey respondents. Impaired cognition was identified as the most important factor that would signal a decline in patient capacity. At least 26% of survey respondents had moral objections to MAiD. Respondents thought that different hypothetical patients had capacity to make a decision about MAiD (range 18%–58%). In other hypothetical scenarios, fewer clinicians were willing to support a MAiD decision for a patient with an oligodendroglioma (26%) vs. glioblastoma (41%–70%, depending on the scenario). Time since diagnosis, performance status, and patient age seemed to affect support for MAiD decisions (Fisher’s exact P-values 0.007, < 0.001, and 0.049, respectively). Conclusion: While there are differing opinions on the moral permissibility of MAiD in general and for neuro-oncology patients, most clinicians agree that capacity must be assessed carefully before a decision is made. End-of-life discussions should happen early, before the capacity is lost. Our results can inform assessments of patient capacity in jurisdictions where MAiD is legal.Keywords
This publication has 24 references indexed in Scilit:
- Euthanasia and Assisted Suicide in Selected European Countries and US StatesMedical Care, 2013
- Why do we want the right to die? A systematic review of the international literature on the views of patients, carers and the public on assisted dyingPalliative Medicine, 2012
- Decision-making in the end-of-life phase of high-grade glioma patientsEuropean Journal of Cancer, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Dying cancer patients talk about euthanasiaSocial Science & Medicine, 2008
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Ethics and Law: Physician-Assisted DyingJournal of Palliative Medicine, 2005
- Competency and the Capacity to Make Treatment DecisionsThe Primary Care Companion For CNS Disorders, 1999
- What's wrong with Bonferroni adjustmentsBMJ, 1998
- An improved Bonferroni procedure for multiple tests of significanceBiometrika, 1986